US Tech Solutions · 1 week ago
Associate Scientist I
US Tech Solutions is a global staff augmentation firm providing a wide range of talent on-demand and total workforce solutions. They are seeking an Associate Scientist I to perform cell-based assays and ligand binding assays, and to support biologic therapeutics portfolio. The ideal candidate will have a proactive approach and thrive in a fast-paced laboratory environment.
Information Technology
Responsibilities
Conduct cell-based and ligand binding assays
Develop, validate, transfer, and troubleshoot immunoassays and cell-based assays to support biologic therapeutics portfolio
Order lab supplies and experimental materials; maintain lab instruments
Other job assignments
Qualification
Required
Bachelor's degree in biological sciences (e.g., Immunology, Biochemistry, Cell Biology, or a related field)
Excellent oral, written, and presentation skills
Ability to manage multiple activities while meeting tight deadlines
Proven ability to maintain excellent working relationships with colleagues
Commitment to the values of integrity and accountability
Preferred
Hands-on laboratory experience in cell culture, flow cytometry assays, and immunoassays
One year of relevant industry experience
Knowledge of basic cell biology, immunology, or pharmacology
Knowledge of relevant global health authority guidelines and industry practices
Company
US Tech Solutions
US Tech Solutions counted among the largest yet the fastest growing staffing firm; all achieved organically.
H1B Sponsorship
US Tech Solutions has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (9)
2023 (13)
2022 (24)
2021 (18)
2020 (14)
Funding
Current Stage
Late StageRecent News
Kelly Services, Inc.
2025-05-17
GlobeNewswire News Room
2024-12-13
Company data provided by crunchbase